Carotid Stenosis and TAVR

Aortic Stenosis affects over 5% of the population over 65. 

Estenosis carotídea y TAVI

Even though TAVR has advanced in the treatment of this disease, many patients present carotid aortic stenosis (CAS), which involves additional surgical risk. This risk has not been thoroughly assessed in the context of TAVR. 

A meta-analysis was carried out including 5 observational studies with a total 111,915 patients. Mean patient age was 83 and 46% were women.

Stroke or transient ischemic attack (TIA) rate was higher in patients presenting CAS (OR 1.44; CI 95% 1.07–1.95; p = 0.016), with no significant differences in myocardial infarction (OR 1.24; CI 95% 1.05–1.47; p = 0.074), all-cause mortality (OR 0.99; CI 95% 0.71–1.37; p = 0.94), acute kidney failure (OR 0.98; CI 95% 0.90–1.06) and the need for pacemaker implantation after TAVR (OR 0.95; CI 95% 0.70–1.30; p = 0.759) between both groups.

Conclusión

This analysis revealed a link between carotid stenosis and cerebrovascular events in patients undergoing TAVR, with no significant impact on all-cause mortality. We highlight the need for prospective studies for a more detailed assessment of additional determinants of this association, such as unilateral or bilateral compromise and stenosis degree, which increases risk. 

Original Title: Impact of carotid artery stenosis on outcomes of transcatheter aortic valve replacement: A systematic review and meta-analysis.

Reference: Lucas Caetano da Silva, et al. International Journal of Cardiology, https://doi.org/10.1016/j.ijcard.2023.131670.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...